Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Doug Shapiro who wrote (3049)	3/25/1998 10:42:00 PM
From: Brander	Respond to of 7041

"I don't think so Brad" You don't think so what? What does the old Asensio report have to do with what I posted? He is reportedly 1,000,000 shares short. Don't you think he might be a little biased? The patent did get approved; Asensio and followers said it wouldn't. The approval of the patent means that Vasomax is unique enough to be granted a patent. That can only be good news for ZONA and it's attempt to obtain FDA approval. Brad

To: Doug Shapiro who wrote (3049)	3/25/1998 11:26:00 PM
From: Bruce Rosen	Read Replies (2) \| Respond to of 7041

Doug, so far your contribution to this board is to repost what everybody knows. Constant repetition of the same nonsense seems to be all the shorts can muster now. Here is some information that came out today. Latest Zonagen short position is 2,757,233. Last month it was 2,836,448. All of 79,215 net coverage of the short position from Feb. 13 to March 13. Is this the terrible market manipulation that Wexler has blamed Zonagen's rise on? The short squeeze has not even begun yet! Well, maybe just a little. :)